The following data is part of a premarket notification filed by Dade Behring, Inc. with the FDA for N Antisera To Human Immunoglobulins (igg, Iga And Igm).
Device ID | K042735 |
510k Number | K042735 |
Device Name: | N ANTISERA TO HUMAN IMMUNOGLOBULINS (IGG, IGA AND IGM) |
Classification | Method, Nephelometric, Immunoglobulins (g, A, M) |
Applicant | DADE BEHRING, INC. P.O. BOX 6101 Newark,, DE 19714 |
Contact | Kathleen A Dray-lyons |
Correspondent | Kathleen A Dray-lyons DADE BEHRING, INC. P.O. BOX 6101 Newark,, DE 19714 |
Product Code | CFN |
CFR Regulation Number | 866.5510 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2004-10-01 |
Decision Date | 2005-02-15 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00842768009846 | K042735 | 000 |
00842768009822 | K042735 | 000 |
00842768009761 | K042735 | 000 |
00842768009747 | K042735 | 000 |